Suppr超能文献

非典型受体介导人脐动脉对内皮素-1和沙罗毒素S6b的反应。

Atypical receptors mediate the response to endothelin-1 and sarafotoxin S6b in the human umbilical artery.

作者信息

Laursen M, Bodelsson G, Stjernquist M

机构信息

Department of Obstetrics and Gynaecology, University Hospital, Malmö, Sweden.

出版信息

Eur J Pharmacol. 1998 Dec 4;362(2-3):167-72. doi: 10.1016/s0014-2999(98)00738-9.

Abstract

The receptors mediating smooth muscle response to endothelin-1 and sarafotoxin S6b in the human umbilical artery were investigated in vitro. Both agonists induced contractions that were unaffected by the endothelin ET(B) receptor antagonist BQ 788 (10(-9), 10(-8), 10(-7) M). The non-selective endothelin ET(A/B) receptor antagonist PD 142893 (10(-7) M) decreased the contraction induced by endothelin-1. PD 142893 (10(-9) M) enhanced the contraction induced by sarafotoxin S6b whereas higher concentrations had no effect. Removing the endothelium did not affect the antagonising action of PD 142893 on endothelin-1-induced contractions while the enhancement of the sarafotoxin S6b-induced contraction was abolished. Sarafotoxin S6b induced relaxation in segments precontracted by 5-hydroxytryptamine and exposed to the endothelin ET(A) receptor antagonist BQ 123 (10(-7) M) and PD 142893 (10(-9) M) abolished this relaxation. These endothelial receptors seem neither to be classical endothelin ET(A) nor endothelin ET(B) receptors and they are not activated by endothelin-1.

摘要

体外研究了介导人脐动脉平滑肌对内皮素 -1 和芋螺毒素 S6b 反应的受体。两种激动剂均诱导收缩,且不受内皮素 ET(B) 受体拮抗剂 BQ 788(10(-9)、10(-8)、10(-7) M)的影响。非选择性内皮素 ET(A/B) 受体拮抗剂 PD 142893(10(-7) M)可减弱内皮素 -1 诱导的收缩。PD 142893(10(-9) M)增强了芋螺毒素 S6b 诱导的收缩,而更高浓度则无作用。去除内皮并不影响 PD 142893 对内皮素 -1 诱导收缩的拮抗作用,而芋螺毒素 S6b 诱导收缩的增强作用则被消除。芋螺毒素 S6b 在由 5 - 羟色胺预收缩并暴露于内皮素 ET(A) 受体拮抗剂 BQ 123(10(-7) M)的节段中诱导舒张,而 PD 142893(10(-9) M)消除了这种舒张。这些内皮受体似乎既不是经典的内皮素 ET(A) 受体也不是内皮素 ET(B) 受体,且它们不会被内皮素 -1 激活。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验